These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18356148)

  • 21. Micronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies.
    Bonassi S; El-Zein R; Bolognesi C; Fenech M
    Mutagenesis; 2011 Jan; 26(1):93-100. PubMed ID: 21164188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smoking, chromosomal aberrations, and cancer incidence in healthy subjects.
    Farkas G; Kocsis ZS; Székely G; Dobozi M; Kenessey I; Polgár C; Jurányi Z
    Mutat Res Genet Toxicol Environ Mutagen; 2021 Jul; 867():503373. PubMed ID: 34266629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosomal aberrations and SCEs as biomarkers of cancer risk.
    Norppa H; Bonassi S; Hansteen IL; Hagmar L; Strömberg U; Rössner P; Boffetta P; Lindholm C; Gundy S; Lazutka J; Cebulska-Wasilewska A; Fabiánová E; Srám RJ; Knudsen LE; Barale R; Fucic A
    Mutat Res; 2006 Aug; 600(1-2):37-45. PubMed ID: 16814813
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining environmental exposure and genetic effect measurements in health outcome assessment.
    Bonassi S
    Mutat Res; 1999 Jul; 428(1-2):177-85. PubMed ID: 10517991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Frequency of chromosomal aberrations in lymphocytes of peripheral blood in patients with solid tumors].
    Semenov AV; Vorobtsova IE
    Vopr Onkol; 2016; 62(3):485-9. PubMed ID: 30463052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosomal aberration analysis in 85 control individuals.
    Carbonell E; Peris F; Xamena N; Creus A; Marcos R
    Mutat Res; 1996 Aug; 370(1):29-37. PubMed ID: 8830804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomere length and LINE1 methylation is associated with chromosomal aberrations in peripheral blood.
    Li H; Hilmarsen HT; Hossain MB; Björk J; Hansteen IL; Albin M; Furu Skjelbred C; Broberg K
    Genes Chromosomes Cancer; 2013 Jan; 52(1):1-10. PubMed ID: 22997064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromosomal aberrations in young cancer patients.
    Bakshi SR; Patel RK; Roy SK; Alladi PA; Trivedi AH; Bhatavdekar JM; Patel DD; Shah PM; Rawal UM
    Cancer Genet Cytogenet; 1999 Dec; 115(2):114-7. PubMed ID: 10598143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromosomal changes: induction, detection methods and applicability in human biomonitoring.
    Mateuca R; Lombaert N; Aka PV; Decordier I; Kirsch-Volders M
    Biochimie; 2006 Nov; 88(11):1515-31. PubMed ID: 16919864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Micronuclei in peripheral blood lymphocytes as a possible cancer risk biomarker: a cohort study of occupationally exposed workers in Croatia.
    Znaor A; Fucić A; Strnad M; Barković D; Skara M; Hozo I
    Croat Med J; 2003 Aug; 44(4):441-6. PubMed ID: 12950148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct pathways associated with chromosomal aberration frequency in a cohort exposed to genotoxic compounds compared to general population.
    Niazi Y; Thomsen H; Smolkova B; Vodickova L; Vodenkova S; Kroupa M; Vymetalkova V; Kazimirova A; Barancokova M; Volkovova K; Staruchova M; Hoffmann P; Nöthen MM; Dusinska M; Musak L; Vodicka P; Hemminki K; Försti A
    Mutagenesis; 2019 Dec; 34(4):323-330. PubMed ID: 31586183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
    Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
    Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer predictive value of cytogenetic markers used in occupational health surveillance programs: a report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health.
    Hagmar L; Bonassi S; Strömberg U; Mikoczy Z; Lando C; Hansteen IL; Montagud AH; Knudsen L; Norppa H; Reuterwall C; Tinnerberg H; Brogger A; Forni A; Högstedt B; Lambert B; Mitelman F; Nordenson I; Salomaa S; Skerfving S
    Mutat Res; 1998 Sep; 405(2):171-8. PubMed ID: 9748557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of sex on cytogenetic end points: evidence from a large human sample and review of the literature.
    Bonassi S; Bolognesi C; Abbondandolo A; Barale R; Bigatti P; Camurri L; Dalpra L; De Ferrari M; Forni A; Lando C
    Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):671-9. PubMed ID: 8547835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocytes with multiple chromosomal damages in a large cohort of West Siberia residents: Results of long-term monitoring.
    Druzhinin V; Bakanova M; Fucic A; Golovina T; Savchenko Y; Sinitsky M; Volobaev V
    Mutat Res; 2016; 784-785():1-7. PubMed ID: 26731314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytogenetic biomonitoring of Indian women cooking with biofuels: micronucleus and chromosomal aberration tests in peripheral blood lymphocytes.
    Musthapa MS; Lohani M; Tiwari S; Mathur N; Prasad R; Rahman Q
    Environ Mol Mutagen; 2004; 43(4):243-9. PubMed ID: 15141363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosomal aberration analysis: Novel noninvasive techniques for early-stage cancer screening.
    Liu G
    Clin Chim Acta; 2024 Jun; 560():119736. PubMed ID: 38763468
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.